GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RaQualia Pharma Inc (TSE:4579) » Definitions » Institutional Ownership

RaQualia Pharma (TSE:4579) Institutional Ownership : 0.40% (As of Jul. 01, 2025)


View and export this data going back to 2011. Start your Free Trial

What is RaQualia Pharma Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, RaQualia Pharma's institutional ownership is 0.40%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, RaQualia Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, RaQualia Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.


RaQualia Pharma Institutional Ownership Historical Data

The historical data trend for RaQualia Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaQualia Pharma Institutional Ownership Chart

RaQualia Pharma Historical Data

The historical data trend for RaQualia Pharma can be seen below:

2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30 2025-05-31
Institutional Ownership 0.54 0.56 0.56 0.56 0.56 0.52 0.49 0.47 0.42 0.40

RaQualia Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


RaQualia Pharma Business Description

Traded in Other Exchanges
N/A
Address
5-2 Taketoyo, Aichi, Taketoyo, JPN, 470-2341
RaQualia Pharma Inc is engaged in the research and development of pharmaceutical compounds.

RaQualia Pharma Headlines

No Headlines